EPIZYME, INC. Deferred Revenue
EPIZYME, INC. had Deferred Revenue of $28.90 million as of 2017-12-31, per its 10-Q filed 2018-08-02.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2018-08-02
- 2017-12-31: Deferred Revenue $28.90M.
| Period end | Deferred Revenue |
|---|---|
| 2017-12-31 | $28.90M 10-Q · filed 2018-08-02 |